Low-dose mesenchymal stem cell therapy for discogenic pain: safety and efficacy results from a 1-year feasibility study

AIM: To evaluate safety and efficacy of low dose autologous adipose-derived mesenchymal stem cells (ADMSCs) for treatment of disc degeneration resulting in low back pain (LBP). METHODS: Nine participants with chronic LBP originating from single-level lumbar disc disease underwent intradiscal injecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bates, Dan, Vivian, David, Freitag, Julien, Wickham, James, Mitchell, Bruce, Verrills, Paul, Shah, Kiran, Boyd, Richard, Federman, Dean, Barnard, Adele, O'Connor, Lera, Young, Jacqui F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136638/
https://www.ncbi.nlm.nih.gov/pubmed/35662742
http://dx.doi.org/10.2144/fsoa-2021-0155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136638/
https://www.ncbi.nlm.nih.gov/pubmed/35662742
http://dx.doi.org/10.2144/fsoa-2021-0155

Ejemplares similares